Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 2:11 PM ET

Date/Time Source News Release
06/02/2025 09:40 AM EDT Business Wire Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics' Phase 1 Study in China of GFH375 (VS-7375), an Oral KRAS G12D (ON/OFF) Inhibitor
05/28/2025 07:30 AM EDT Business Wire Verastem Oncology to Present at the Jefferies Global Healthcare Conference
05/22/2025 05:01 PM EDT Business Wire Verastem Oncology Announces Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in Frontline Metastatic Pancreatic Ductal Adenocarcinoma
05/13/2025 04:34 PM EDT Business Wire Verastem Oncology Reports First Quarter 2025 Financial Results and Highlights Recent Business Updates
05/08/2025 01:17 PM EDT Business Wire FDA Approves the AVMAPKI(TM) FAKZYNJA(TM) Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated Recurrent Low-Grade Serous Ovarian Cancer
05/01/2025 07:30 AM EDT Business Wire Verastem Oncology to Present at Upcoming Investor Conferences
04/25/2025 09:00 AM EDT Business Wire Verastem Oncology Announces $75 million Private Placement
04/23/2025 04:05 PM EDT Business Wire Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors
04/07/2025 07:30 AM EDT Business Wire Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/25/2025 04:35 PM EDT Business Wire Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025
Page

Additional News

As of June 4, 2025 • 2:11 PM ET

Date/Time Source News Release
06/02/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: AI Infrastructure and Pharma Indices Jump On Lease Deal and Trial Results
05/28/2025 10:43 AM EDT Zacks VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval
05/27/2025 09:50 AM EDT Baystreet AI in Medicine Nears Tipping Point as Predictive Diagnostics Gain FDA Momentum
05/22/2025 03:47 PM EDT SeekingAlpha Tempus AI: I Believe In The Company's Cause
05/20/2025 09:27 AM EDT SeekingAlpha Tempus AI teams up with Verastem for companion diagnostic test
05/14/2025 02:01 PM EDT PRISM News Earnings Insights: Verastem Oncology Gears Up for a Transformational Year with FDA Approval and Expanding Pipeline
05/13/2025 05:06 PM EDT SeekingAlpha Verastem Non-GAAP EPS of -$0.79 misses by $0.01
05/13/2025 04:57 PM EDT SeekingAlpha Verastem files to sell 3.43M shares of common stock for holders
05/08/2025 12:47 PM EDT SeekingAlpha Verastem's Avmapki Fakzynja receives FDA accelerated approval for ovarian cancer
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.